VEGFA and diabetic retinopathy: The Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol I and T studies showed that, after an initial anti-VEGF treatment period, central-involved DME remained persistent in a significant number of patients (51–73%) at 12 weeks [8–11].